Dynavax Technologies Corp.
(NASDAQ : DVAX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.93%240.931.3%$857.67m
MRNAModerna, Inc. -2.18%67.750.0%$761.08m
NVAXNovavax, Inc. -2.57%107.3296.5%$689.21m
IMMUImmunomedics, Inc. -0.13%85.3011.0%$663.23m
GILDGilead Sciences, Inc. -1.31%63.371.0%$581.92m
REGNRegeneron Pharmaceuticals, Inc. 0.00%555.722.7%$450.22m
ILMNIllumina, Inc. -1.62%265.763.5%$381.22m
BIIBBiogen, Inc. -0.22%267.721.6%$335.30m
VRTXVertex Pharmaceuticals, Inc. -1.32%260.511.9%$325.73m
ALXNAlexion Pharmaceuticals, Inc. -0.10%111.632.0%$276.12m
SRNESorrento Therapeutics, Inc. -4.05%9.361.5%$266.58m
VXRTVaxart, Inc. -4.56%8.580.0%$245.26m
MNTAMomenta Pharmaceuticals, Inc. -0.02%52.363.0%$213.07m
SGENSeattle Genetics, Inc. -0.46%178.016.0%$202.90m
BMRNBioMarin Pharmaceutical, Inc. -1.87%75.844.3%$198.13m

Company Profile

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.